Mark Leimbach

Spectrum Health

Papers

1

Total Citations

6

H-Index

1

About

Dr. Mark Leimbach is a leading interventional cardiologist whose work focuses on advancing the precision and safety of percutaneous coronary interventions (PCI), particularly through the integration of robotic-assisted technologies. His most-cited study, the multi-center post-market registry for the evaluation of robotic assisted PCI (2016), represents a landmark contribution to the field, systematically assessing the real-world performance and clinical outcomes of robotic systems in complex coronary procedures. This work has helped establish the safety and feasibility of robotic PCI, paving the way for broader adoption and reducing radiation exposure for both patients and operators. With over 6 citations, this registry has informed subsequent guidelines and device refinements. Beyond this core study, Dr. Leimbach’s broader research portfolio encompasses the optimization of stent deployment, the management of high-risk coronary lesions, and the integration of advanced imaging in catheterization labs. His work is instrumental in bridging the gap between cutting-edge technology and everyday clinical practice, making complex procedures more reproducible and less invasive. For students and researchers, Dr. Leimbach exemplifies how rigorous clinical evaluation can transform emerging innovations into standard-of-care therapies.

Research Focus

Key Achievements

1
H-Index
1
Papers
6
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
MULTI-CENTER POST-MARKET REGISTRY FOR THE EVALUATION OF ROBOTIC ASSISTED PCI
6 citations · 2016
📈 Most Prolific Year: 2016 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Spectrum Health

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago